Compugen Ltd., a clinical-stage cancer immunotherapy company, announced it will present its AI-powered discovery platform, UnigenX™, at the 18th Annual Protein and Antibody Engineering Summit (PEGS) Europe in November 2026. UnigenX™ focuses on discovering novel tumor-associated antigens and targeted immune activation therapies like T cell engagers. This presentation highlights Compugen's advancements in computational target discovery and its pipeline of innovative cancer treatments, including antibodies in clinical trials. The event underscores Compugen's role in advancing AI-driven cancer immunotherapy research.
Compugen's upcoming presentation of its UnigenX™ platform is noted here alongside Pluang's health sector market snapshot as of Nov 10, 2026 18:42 WIB. Among 150 priced health-sector US stocks tradable on Pluang, 85 rose and 56 fell today. Notable movers include FLNA at USD 0.53 with a 7.80% increase and a typical hold time of 39 days, CGC at USD 0.65 up 4.37% with a 40-day hold, and ABCL at USD 12.96 rising 3.68% with a 42-day hold time.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
